Invasive pneumococcal disease burden and implications for vaccine policy in urban Bangladesh

W Abdullah Brooks1, Robert F Breiman, Doli Goswami

  • 1ICDDR,B, Mohakhali, Dhaka, Bangladesh. abrooks@icddrb.org

Insights

Invasive pneumococcal disease (IPD) surveillance in Bangladesh revealed high incidence and significant antimicrobial resistance in children under five. Conjugate vaccines are expected to reduce IPD, pneumonia, and resistance.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Epidemiology

Background:

  • Invasive pneumococcal disease (IPD) poses a significant threat to young children globally.
  • Population-based data on IPD incidence, serotype distribution, and antimicrobial resistance in Bangladesh were previously lacking.
  • Understanding these factors is crucial for public health interventions.

Purpose of the Study:

  • To determine the incidence and serotype distribution of IPD in children under five years old in urban Bangladesh.
  • To describe the clinical presentation and antimicrobial resistance patterns of IPD.
  • To evaluate the potential impact of conjugate vaccines on IPD and related outcomes.

Main Methods:

  • Active, population-based surveillance was conducted in 5,000 urban households.
  • Blood cultures were collected from eligible children aged <5 years between April 2004 and March 2006.
  • Isolation of Streptococcus pneumoniae and antimicrobial susceptibility testing were performed.

Main Results:

  • A total of 34 cases of IPD were identified among 6,167 eligible children.
  • Overall IPD incidence was 447 episodes/100,000 child-years, with 13-valent serotype-related IPD incidence at 276 episodes/100,000 child-years.
  • High rates of resistance were observed for cotrimoxazole (82.4%), ciprofloxacin (24.1%), and chloramphenicol (14.7%).

Conclusions:

  • IPD incidence, particularly related to vaccine serotypes, is substantial in young Bangladeshi children.
  • High antimicrobial resistance necessitates careful treatment strategies and highlights the importance of vaccination.
  • Current conjugate vaccines are anticipated to significantly decrease IPD, childhood pneumonia, and antimicrobial resistance in Bangladesh.

Related Concept Videos

Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...